Influenza virus

Transfusion Medicine and Hemotherapy

Volumn 36, Issue 1, 2009, Pages 32-39

  Blümel, Johannes ^b   Burger, Reinhard ^b   Drosten, Christian ^b   Gröner, Albrecht ^b   Gürtler, Lutz ^b   Heiden, Margarethe ^b   Hildebrandt, Martin ^b   Jansen, Bernd ^b   Klamm, Horst ^b   Montag Lessing, Thomas ^b   Offergeld, Ruth ^b   Pauli, Georg ^b   Seitz, Rainer ^b   Schlenkrich, Uwe ^b   Schottstedt, Volkmar ^b   Willkommen, Hannelore ^b   Von König, Carl Heinz Wirsing ^b   Schweiger, Brunhilde ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; GLYCOPROTEIN; HEMAGGLUTININ; MATRIX PROTEIN; OSELTAMIVIR; RIMANTADINE; SIALIDASE; ZANAMIVIR;

ANTIGEN DETECTION; BLOOD DONOR; DISEASE SEVERITY; DISEASE TRANSMISSION; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS B; MORTALITY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SEROLOGY; VIRUS CULTURE; VIRUS TRANSMISSION;

EID: 60149103491     PISSN: 16603796     EISSN: None     Source Type: Journal    
DOI: 10.1159/000197314     Document Type: Review

References (53)

1. Wright PF, Webster RG: Orthomyxoviruses; in Fields BN, Knipe DM, Howley PM, et al (eds): Fields Virology, 4th ed. Philadelphia, Lippincott Williams and Wilkins, 2001, pp 1533 ff.
2. Scholtissek C: Stability of infectious influenza A viruses at low pH and at elevated temperature. Vaccine 1985;3(suppl 1):215-218.
3. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B, Osterhaus AD: Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005;79:2814-2822.
4. Rota PA, Wallis TR, Harmon MW, Rota JS, Kendal AP, Nerome K: Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 1990;175:59-68.
5. Nerome R, Hiromoto Y, Sugita S, Tanabe N, Ishida M, Matsumoto M, Lindstrom SE, Takahashi T, Nerome K: Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism. Arch Virol 1998;143:1569-1583.
6. Scholtissek C, Rohde W, Von Hoyningen V, Rott R: On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978;87:13-20.
7. Kawaoka Y, Krauss S, Webster RG: Avian-tohuman transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989;63:4603-4608.
8. World Health Organization: Avian Influenza. www.who.int/csr/disease/ avian-influenza/en/index.html.
9. Lyytikäinen O, Hoffmann E, Timm H, Schweiger B, Witte W, Vieth U, Ammon A, Petersen LR: Influenza A outbreak among adolescents in a ski hostel. Eur J Clin Microbiol Infect Dis 1998;17:128-130.
10. Thomas P, Riffelmann M, Schweiger B, Dominik S, von Konig CH: Fatal influenza A virus infection in a child vaccinated against influenza. Pediatr Infect Dis J 2003;22:201-202.
11. Laing R, Slater W, Coles C, Chambers S, Frampton C, Jackson R, Jennings L, Karalus N, Mills G, Murdoch D, Town I: Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology. N Z Med J 2001;114:488-492.
12. Oliveira EC, Marik PE, Colice G: Influenza pneumonia: a descriptive study. Chest 2001;119:1717-1723.
13. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld M, Le TP, Truong HK, Nguyen VV, Tran TH, Do QH, Farrar J: Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005;352:686-691.
14. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY; Writing Committee of the World Health Organization (WHO) Consultation on human influenza A/H5: Avian influenza A (H5N1) infection in humans. N Engl J Med 2005;353:1374-1385.
15. Yu H, Shu Y, Hu S, Zhang H, Gao Z, Chen H, Dong J, Xu C, Zhang Y, Xiang N, Wang M, Guo Y, Cox N, Lim W, Li D, Wang Y, Yang W: The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet 2006;367(9504):84.
16. Webster RG: Influenza: An Emerging Disease. Emerg Infect Dis 1998;4:436-441.
17. Webster RG: The importance of animal influenza for human disease. Vaccine 2002;20(suppl 2):16-20.
18. Gregory V, Bennett M, Orkhan MH, Al Hajjar S, Varsano N, Mendelson E, Zambon M, Ellis J, Hay A, Lin YP: Emergence of influenza A (H1N2) reassortant viruses in the human population during 2001. Virology 2002;300:1-7.
19. Fauci AS: () Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006;194(suppl 2):S73-S76.
20. Zucs P, Buchholz U, Haas W, Uphoff H: Influenza associated excess mortality in Germany, 1985-2001. Emerg Themes Epidemiol 2005;2:6.
21. Arbeitsgemeinschaft Influenza (AGI): Saisonberichte. www.influenza. rki.de/agi.
22. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K: Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003;289:179-186.
23. Schweiger B, Zadow I, Heckler R: Antigenic drift and variability of influenza viruses. Med Microbiol Immunol 2002;191:133-138.
24. Schweiger B: Molecular characterization of human influenza viruses - a look back on the last 10 years. Berl Munch Tierarztl Wochenschr 2006;119:167-178.
25. Schweiger B: Nationale und globale Influenzasurveillance als Basis der jährlichen Impfstoffempfehlung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2001;44:1153-1161.
26. Coonrod JD, Karathanasis P, Betts RF, Donofrio JC: Enzyme-linked immunosorbent assay of core antigens for clinical diagnosis of influenza. J Med Virology 1988;25:399-409.
27. Johnston SLG, Siegel CS: A comparison of direct immunofluorescence, shell vial culture, and conventional cell culture for the rapid detection of influenza A and B. Diagn Microbiol Infect Dis 1991;14:131-134.
28. Gleaves CA, Brown JA: Detection of influenza A in clinical specimens and cell culture fluid by a commercial EIA. Clin Diagn Virol 1993;1:123-127.
29. Ruest A, Michaud S, Deslandes S, Frost EH: Comparison of the Directigen Flu A+B test, the Quick-Vue Influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 2003;41:3487-3493.
30. Booth S, Baleriola C, Rawlinson WD: Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection. J Med Virol 2006;78:619-622.
31. Donofrio JC, Coonrod JD, Davidson JN, Betts RF: Detection of influenza A and B in respiratory secretions with the polymerase chain reaction. PCR Meth Applicat 1992;1:263-268.
32. Wright KE, Wilson GAR, Novosad D, Dimock C, Tan D, Weber JM: Typing and subtyping of influenza viruses in clinical samples by PCR. J Clin Microbiol 1995;33(5):1180-1184.
33. Claas ECJ, Sprenger MJW, Kleter GEM, van Beek R, Quint WGV, Masurel N: Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction. J Virol Methods 1992;39:1-13.
34. Yamada A, Imanishi J: Detection of influenza B virus in throat swabs using the polymerase chain reaction. Acta Virol 1992;36:320-325.
35. Schweiger B, Lange I, Heckler R, Willers H, Schreier E: Rapid detection of influenza A neuraminidase subtypes by cDNA amplification coupled to a simple DNA enzyme immunoassay. Arch Virol 1994;139:439-444.
36. Cherian T, Bobo L, Steinhoff MC, Karron RA, Yolken RH: Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus. J Clin Microbiol 1994;32:623-628.
37. Zhang WD, Evans DH: Detection and identification of human influenza viruses by the polymerase chain reaction. J Virol Methods 1991;33:165-189.
38. Schweiger B, Zadow I, Heckler R, Timm H, Pauli G: Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 2000;38:1552-1558.
39. WHO Global Influenza Preparedness Plan. The Role of WHO and Recommendations for National Measures before and during Pandemics. WHO/CDS/CSR/GIP/2005.5.
40. Bekanntmachung der Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie) gemäß §§ 12 und 18 des Transfusionsgesetzes (TFG) (Novelle 2005) vom 19. September 2005. Bundesanzeiger (Sonderheft) Nr. 209a, Jahrgang 57, vom 05.11.2005.
41. Nichol KL: Complications of influenza and benefits of vaccination. Vaccine 1999;17(suppl 1):S47-S52.
42. Vu T, Farish S, Jenkins M, Kelly H: A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002;20:1831-1836.
43. Hayden FG: Antiviral resistance in influenza viruses - implications for management and pandemic response. N Engl J Med 2006;354:785-788.
44. Hayden FG, Pavia AT: Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006;194(suppl 2):S119-126.
45. Cheung CL, Rayner JM, Smith GJ, Wang P, Naipospos TS, Zhang J, Yuen KY, Webster RG, Peiris JS, Guan Y, Chen H: Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 2006;193:1626-1629.
46. Baz M, Abed Y, McDonald J, Boivin G: Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child. Clin Infect Dis 2006;43:1555-1561.
47. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y:Avian flu: isolation of drug-resistant H5N1 virus. Nature 2005;437:1108.
48. Ausschuss für biologische Arbeitsstoffe (ABAS): Arbeitsschutz beim Auftreten von nicht impf präven - tabler Influenza unter besonderer Be rücksichtigung des Atemschutzes. Beschluss 609. www.baua.de/nn-15408/de/ Themen-von-A-Z/Biologische- Arbeitsstoffe/TRBA/pdf/Beschluss-609.pdf.
49. Lehmann NI, Gust ID: Viraemia in influenza. A report of two cases. Med J Aust 1971;2:1166-1169.
50. Stanley ED, Jackson GG:Viremia in Asian influenza. Trans Assoc Am Phys 1966;79:376-387.
51. Khakpour M, Saidi A, Naficy K: Proved viraemia in Asian influenza (Hong Kong variant) during incubation period. Br Med J 1969;4:208-209.
52. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207.
53. Kreil TR, Unger U, Orth SM, Petutschnig G, Kistner O, Poelsler G, Berting A: H5N1 influenza virus and the safety of plasma products. Transfusion 2007;47:452-459.